NCT06302634 Cardio-Oncology Rehabilitation Care Process
| NCT ID | NCT06302634 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital Clinico Universitario de Santiago |
| Condition | Cardio-Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2022-06-22 |
| Primary Completion | 2027-06-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2022-06-22 with a primary completion date of 2027-06-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this observational study is to assess the outcomes of a hospital-based Cardio-Oncology Rehabilitation (CORe) program focused on exercise in cancer patients undergoing cardiotoxic treatment. This evaluation will be conducted by analyzing disease-related health indicators, functional capacity, and quality of life. Patients at risk of cardiotoxicity attending the Cardio-Onco-Hematology Unit will be offered the exercise program, which includes two modalities: in-person (center-based) and remote (home-based) options. The assignment to either modality is non randomized, based on the functional assessment conducted in the Rehabilitation Unit and the agreement between healthcare professional and patient. All participants will perform a 3-month supervised exercise intervention. There are 3 time points for assessment: at baseline (T0), 3-month after the exercise program (T1) and follow-up at 9 months from baseline (T2).
Eligibility Criteria
Inclusion Criteria: * High risk of cancer treatment-related cardiotoxicity * Possibility of completing a cardio-onco rehabilitation program (centre-based or home-based) and programmed visits. * Providing written informed consent. Exclusion Criteria: * Patients with physical or mental limitation to carry out an exercise program.
Contact & Investigator
Carlos Peña-Gil, MD, PhD
STUDY DIRECTOR
Hospital Clinico Universitario de Santiago
Frequently Asked Questions
Who can join the NCT06302634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Cardio-Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06302634 currently recruiting?
Yes, NCT06302634 is actively recruiting participants. Contact the research team at estibaliz.diaz.balboa@sergas.es for enrollment information.
Where is the NCT06302634 trial being conducted?
This trial is being conducted at Santiago de Compostela, Spain.
Who is sponsoring the NCT06302634 clinical trial?
NCT06302634 is sponsored by Hospital Clinico Universitario de Santiago. The principal investigator is Carlos Peña-Gil, MD, PhD at Hospital Clinico Universitario de Santiago. The trial plans to enroll 300 participants.